Lung cancer, a leading cause of cancer-related deaths globally, is characterized by significant genomic instability, which is a hallmark of various cancers.
Your lungs may be aging faster than you realize. Learn the hidden signs of declining lung function and how to protect your ...
A COVID-19 study done at the University of Virginia (UVA) has the potential to create new treatment approaches for chronic ...
Dealbreaker on MSN1d
Beam Base Editor’s Early Data in Rare Liver Disease Tee Up $500M Stock Sale in Tough MarketA Beam Therapeutics gene-editing therapy designed to fix a mutation at the root of a rare liver protein deficiency now has early signs of efficacy along with safety data that ease some concerns about ...
The Cambridge-based company touted the data as evidence of the first successful use of CRISPR gene editing to fix a ...
Catalyst Pharmaceuticals' current stock price only assumes historical momentum for existing drug portfolio continues. See why ...
The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely ...
Researchers have uncovered changes in the cellular response throughout lung damage caused by SARS-CoV-2—the virus behind ...
While initial study results suggest Beam's technology can correct alpha-1 antitrypsin deficiency's genetic roots, shares fell ...
The one-time therapy appears to correct the mutation that causes the disease, known as Alpha-1 antitrypsin deficiency (AATD), ...
Researchers at Washington University School of Medicine in St. Louis have uncovered why some patients with a rare genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback